PerampaAIAN
Annals of Indian Academy of Neurology
  Users Online: 9250 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
LETTERS TO THE EDITOR
Year : 2022  |  Volume : 25  |  Issue : 3  |  Page : 511
 

Cerebral Malaria, COVID-19 and complete blood examination


1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India

Date of Submission21-Sep-2021
Date of Acceptance24-Sep-2021
Date of Web Publication13-Jan-2022

Correspondence Address:
Rujittika Mungmunpuntipantip
Private Academic Consultant, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.aian_839_21

Rights and Permissions

 



How to cite this article:
Mungmunpuntipantip R, Wiwanitkit V. Cerebral Malaria, COVID-19 and complete blood examination. Ann Indian Acad Neurol 2022;25:511

How to cite this URL:
Mungmunpuntipantip R, Wiwanitkit V. Cerebral Malaria, COVID-19 and complete blood examination. Ann Indian Acad Neurol [serial online] 2022 [cited 2022 Aug 9];25:511. Available from: https://www.annalsofian.org/text.asp?2022/25/3/511/335397




Dear Editor,

We read the report by Ram et al.[1] with great interest. Ram et al.[1] reported on the co-occurrence of COVID-19 and malaria and concluded that “Every suspected case of COVID encephalitis has to be investigated for all possible causes …….” In the present report, it is likely that there is a problem in the first complete blood count examination. In laboratory medicine, a blood smear examination should be routinely done, and it is usually neglected when an automated hematology analyzer is widely used. Because the incubation period for COVID-19 (14 days) and cerebral malaria (12 days) can overlap, it is no doubt that there might be a co-infection and a disease might be underdiagnosed.[2] Also, it is possible that malaria might be a recurrence, not a newly acquired infection, and co-manifest with COVID-19.[3] When hydroxychloroquine is used for the management of COVID-19, it might also manage malaria co-infection in some cases and co-infection might be finally underdiagnosed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Ram A, Padmanabhan S, Warrier AR, Wilson A. Cerebral malaria in a patient with COVID-19. Ann Indian Acad Neurol 2021;24:616-7.  Back to cited text no. 1
  [Full text]  
2.
Sardar S, Sharma R, Alyamani TYM, Aboukamar M. COVID-19 and plasmodium vivax malaria co-infection. IDCases 2020;21:e00879.  Back to cited text no. 2
    
3.
Pusparani A, Henrina J, Cahyadi A. Co-infection of COVID-19 and recurrent malaria. J Infect Dev Ctries 2021;15:625-9.  Back to cited text no. 3
    




 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (349 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed418    
    Printed25    
    Emailed0    
    PDF Downloaded27    
    Comments [Add]    

Recommend this journal